Medivation Announces Second Quarter Financial Results Teleconference and Webcast on August 9, 2011
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 08/02/11 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a teleconference and webcast with management to discuss second quarter financial results and provide a general business update on Tuesday, August 9, 2011 at 4:30 p.m. Eastern Time. A press release for the second quarter ended on June 30, 2011 will be released after markets close on August 9, 2011.
Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals interested in listening to the live call via webcast may do so by visiting . A replay of the webcast will be available on the Company's website for 30 days.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Astellas and Pfizer, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer and mild-to-moderate Alzheimer's disease. For more information, please visit us at .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.08.2011 - 12:00 Uhr
Sprache: Deutsch
News-ID 40587
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 203 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Second Quarter Financial Results Teleconference and Webcast on August 9, 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation, Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
